Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.

Previously, we have shown somatostatin receptor (SSTR) subtype-specific regulation of growth hormone (GH), thyroid-stimulating hormone, and prolactin (PRL) secretion in human fetal pituitary cultures, where GH and thyroid-stimulating hormone are mediated by both SSTR2 and SSTR5, whereas SSTR2 prefer...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Shimon, I, Yan, X, Taylor, J E, Weiss, M H, Culler, M D, Melmed, S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC508437/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9410919/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI119779
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!